BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8165931)

  • 1. [Imidazoline receptors. Historic review and current status of knowledge].
    Moura D
    Acta Med Port; 1993 Dec; 6(12):599-604. PubMed ID: 8165931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of imidazolines and imidazoline receptors role at the vascular level.
    Serban DN; Nechifor M; Slătineanu SM
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):37-44. PubMed ID: 12089957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.
    Radwanska A; Dlugokecka J; Wasilewski R; Kaliszan R
    J Physiol Pharmacol; 2009 Mar; 60(1):131-42. PubMed ID: 19439815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.
    Greney H; Ronde P; Magnier C; Maranca F; Rascente C; Quaglia W; Giannella M; Pigini M; Brasili L; Lugnier C; Bousquet P; Dontenwill M
    Mol Pharmacol; 2000 Jun; 57(6):1142-51. PubMed ID: 10825384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
    Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoceptors.
    Hieble JP; Ruffolo RR
    Ann N Y Acad Sci; 1995 Jul; 763():8-21. PubMed ID: 7677390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test.
    Zeidan MP; Zomkowski AD; Rosa AO; Rodrigues AL; Gabilan NH
    Eur J Pharmacol; 2007 Jun; 565(1-3):125-31. PubMed ID: 17445795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of alpha2-adrenergic and I1-imidazoline receptors in the effects of clonidine and moxonidine on isolated large intestine of mice].
    Kozaeva LP; Korobov NV; Medvedev OS
    Eksp Klin Farmakol; 2005; 68(1):36-8. PubMed ID: 15786962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a second generation of centrally acting antihypertensive drugs really exist?
    Feldman J; Greney H; Monassier L; Vonthron C; Bruban V; Dontenwill M; Bousquet P
    J Auton Nerv Syst; 1998 Oct; 72(2-3):94-7. PubMed ID: 9851557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazoline Receptor System: The Past, the Present, and the Future.
    Bousquet P; Hudson A; García-Sevilla JA; Li JX
    Pharmacol Rev; 2020 Jan; 72(1):50-79. PubMed ID: 31819014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the imidazoline receptors in toxicology.
    Lowry JA; Brown JT
    Clin Toxicol (Phila); 2014 Jun; 52(5):454-69. PubMed ID: 24666288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of I1 and I2 imidazoline receptors in striatum membranes from different species.
    Vauquelin G; De Backer JP; Ladure P; Flamez A
    Ann N Y Acad Sci; 1999 Jun; 881():135-43. PubMed ID: 10415909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
    Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.
    Velliquette RA; Ernsberger P
    J Pharmacol Exp Ther; 2003 Aug; 306(2):646-57. PubMed ID: 12756274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.